|
|
La lettre / Jeudi 15 juin 2023
|
|
|
|
|
|
|
|
|
|
Une découverte scientifique d'Aelis Farma avec des chercheurs du Neurocentre Magendie et Columbia University (NY) dans Nature Medicine.
|
|
|
|
|
|
|
|
Édité par la SATT Aquitaine
|
|
|
|
|
|
|
|
|
|
|
|
Par l'Inserm. Phase I (théorique) à Bordeaux, du 16 au 18 octobre. Phase II (pratique) du 6 au 10 novembre à Paris.
|
|
|
|
|
|
|
|
|
|
LACCO series: Genetically encoded fluorescent L-lactate biosensors for neuroscience
Invited by Giovanni Marsicano (Neurocentre Magendie)
|
GENIGMA: an app to map the 3D genome of cancer celle lines through extreme citizen science
|
Neuropsychological and cerebral sequelae of Intimate Partner Violence
Invited by Michel Thiebaut de Schotten (IMN)
|
Seminar – Lilly Bentall
Thursday 22 June / 11:00
Changes in SNpr activity underlying dyskinesia in Parkinsonian model rats
Invited by Clémentine Bosch Bouju (NutriNeuro)
|
Social behavior and striatum: reward matters
Invited by Jean-Luc Morel (INCIA)
|
|
|
|
|
|
Cajal lectures
June 19 - 11:00am
Ragnhildur Thora Karadottir (Cambridge University, UK) or Cagla Eroglu (Duke University, USA)
|
June 22 - 9:00am
Wiebke Moebius (Max-Planck Institute of Multidisciplinary Sciences, Germany)
Exploring myelin biology with electron microscopy.
|
June 22 - 10:00am
3 Brain : Presentation
|
June 22 - 11:00am
Amit Agarwal (Heidelberg University, Germany)
Decoding calcium signals and mitochondrial dynamics in brain macroglia in vivo.
|
June 23 - 9:00am
Thomas Papouin (Washington University, School of Medicine , USA)
Mapping the Contribution of Astrocytes to the Effects of Neuromodulators on Synapses and Behavior.
|
June 23 - 11:00am
Mikael Simons (DZNE, Germany)
Mechanisms of (re)myelination in the CNS.
|
June 24 - 9:00am
Caroline Smith (Boston College, USA)
Conducting rigorous behavioral testing in the context of neuro-immune interactions.
|
June 24 - 10:00am
Giampaolo Milior (College de France, France)
Glial cells in the human brain: new insights and perspectives from work on human epileptic tissues.
|
|
|
|
|
|
|
|
|
|
Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11β-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency
Julie Brossaud, Clémentine Bosch-Bouju, Nathalie Marissal-Arvy, Marie-Neige Campas-Lebecque, Jean-Christophe Helbling, Scott P. Webster, Brian R. Walker, Xavier Fioramonti, Guillaume Ferreira, Pascal Barat, Jean-Benoît Corcuff, Marie-Pierre Moisan.
Diabetologia. 2023-06-10
10.1007/s00125-023-05942-3
|
|
|
|
|
|
|
|
|
|
New calls
|
|
rejuvenation biotechnology
|
|
Vise à entamer une nouvelle collaboration entre un jeune chercheur ou chercheuse Inserm travaillant dans une équipe française et une équipe étrangère.
|
|
Applicants at accredited US and international institutions are eligible.
|
|
To undertake a flexible 12 month period of sabbatical leave in a UK university or research institution
|
|
Pour les statutaires dans un laboratoire sous tutelle du CNRS
|
|
Chan Zuckerberg Initiative
|
|
Collaborative, cross-disciplinary research project in the field of imaging and data science
|
|
Pour doctorant(e)s et post-doctorant(e)s
|
|
Expire le 30 octobre 2023
|
|
|
|
|
|
Ending soon
|
Biological or medical research.
|
|
Soutien fort et durable à des équipes proposant un programme de recherche innovant en biologie avec des applications potentielles en santé
|
|
intended to support multi-disciplinary teams of PIs with expertise in both human and animal research
|
|
Tremblement essentiel mais aussi tremblements rares
|
|
Celebrating outstanding support and mentorship in science
|
|
Deux bourses avec le soutien des laboratoires Pfizer et CSL Behring
|
|
Autism Science Foundation
|
|
AFAF et Fondation Maladies Rares . Toutes les disciplines biomédicales, paramédicales et des sciences humaines et sociales sont éligibles
|
|
Par l’Association Connaître les syndromes cérébelleux (CSC) et la Fondation Maladies Rares (FMR)
|
|
Enables the evaluation of novel therapeutics for target engagement and disease-modifying potential in ALS.
|
|
|
|
|
|
|
|
|
|
